Concepedia

Hong Mu

HM

40

Publications

3.2K

Citations

29

H-Index

1995

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

University of Utah

Southern Medical University

Michael E. DeBakey VA Medical Center

Hong Mu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1995–2022

40

Publications

40

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 717 citations · Full text

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Rongqing Pan, Vivian Ruvolo, Hong Mu et al. · Cancer Cell · 2017 · 299 citations · Full text

, , +8

ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies

Jo Ishizawa, Kensuke Kojima, Dhruv Chachad et al. · Science Signaling · 2016 · 197 citations · Full text

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells

Bing Z. Carter, Po Yee Mak, Hong Mu et al. · Science Translational Medicine · 2016 · 168 citations · Full text

Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia

Sujan Piya, Steven M. Kornblau, Vivian Ruvolo et al. · Blood · 2016 · 120 citations · Full text

Rows per page

1–5 of 40